Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.
Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.
复制标题
偏斜的表观遗传学:糖尿病并发症的替代治疗选择。
DOI:
10.1155/2015/373708
复制
发表时间:
2015
影响因子:
4.3
通讯作者:
Brizzi MF
中科院分区:
文献类型:
--
作者:
Togliatto G;Dentelli P;Brizzi MF
Vascular complications are major causes of morbidity and mortality in type 2 diabetes patients. Mitochondrial reactive oxygen species (ROS) generation and a lack of efficient antioxidant machinery, a result of hyperglycaemia, mainly contribute to this problem. Although advances in therapy have significantly reduced both morbidity and mortality in diabetic individuals, diabetes-associated vascular complications are still one of the most challenging health problems worldwide. New healing options are urgently needed as current therapeutics are failing to improve long-term outcomes. Particular effort has recently been devoted to understanding the functional relationship between chromatin structure regulation and the persistent change in gene expression which is driven by hyperglycaemia and which accounts for long-lasting diabetic complications. A detailed investigation into epigenetic chromatin modifications in type 2 diabetes is underway. This will be particularly useful in the design of mechanism-based therapeutics which interfere with long-lasting activating epigenetics and improve patient outcomes. We herein provide an overview of the most relevant mechanisms that account for hyperglycaemia-induced changes in chromatin structure; the most relevant mechanism is called “metabolic memory.”
登录
查看更多内容
影响因子:
7.4
作者:
Kato, Mitsuo;Castro, Nancy E.;Natarajan, Rama
通讯作者:
Natarajan, Rama
影响因子:
158.5
作者:
Holman, Rury R.;Paul, Sanjoy K.;Neil, H. Andrew W.
通讯作者:
Neil, H. Andrew W.
影响因子:
15.9
作者:
Brizzi, MF;Dentelli, P;Pegoraro, L
通讯作者:
Pegoraro, L
影响因子:
7.7
作者:
Feng B;Chen S;McArthur K;Wu Y;Sen S;Ding Q;Feldman RD;Chakrabarti S
通讯作者:
Chakrabarti S
影响因子:
2.7
作者:
Bell CG;Teschendorff AE;Rakyan VK;Maxwell AP;Beck S;Savage DA
通讯作者:
Savage DA